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II. Structure of the thesis 
 
This thesis consists of the three chapters introduction (Chaper 1), results (Chapter 2) and 
summarizing discussion (Chapter 3). The introduction part (Chapter 1) is composed of 3 
subchapters. The first part describes the properties, applications and impact of 
nanomaterials with a special focus on copper oxide nanoparticles (Chapter 1.1). The 
second part describes the role of astrocytes as a central key player in the brain 
homeostasis (Chapter 1.2). The last part of the introduction is a publication reviewing 
the handling of copper and copper oxide nanoparticles by astrocytes (Chapter 1.3). 
 
The results part of this thesis consists of three publications (Capter 2.1-2.3) and the 
description and analysis of an unpublished dataset (Chapter 2.4), describing the effects 
of copper and copper oxide nanoparticles on astrocytes. In the summarizing discussion 
(Chapter 3), which is the third and last part of this thesis, the most important results of 
this thesis will be discussed and future perspectives will be elucidated.  
 
The contributions of all authors to publications are listed on the first page of the 
corresponding chapter.  
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III. Summary 
 
Copper oxide nanoparticles (CuO-NPs) recently raised the industry’s interest due to 
their interesting chemical and physical properties. The continuous increase of products 
containing CuO-NPs and the unintentional generation of CuO-NPs by technical 
processes establish an increased risk of human exposure. Since nanoparticles can reach 
the brain upon exposure, it is of high interest to evaluate the uptake and potential 
adverse effects on brain cells. In this context astrocytes are of special interest due to 
their central role in the brain homeostasis and in defence processes. 
In the presented thesis, a method for the synthesis of CuO-NPs was established. After a 
detailed analysis of the physico-chemical properties of the synthesized CuO-NPs, 
primary astrocytes cultures were exposed to these CuO-NPs. The accumulation and 
uptake mechanism of CuO-NPs by cultured astrocytes as well as the resulting effects on 
the cell vitality and metabolism were investigated. It was shown that cultured astrocytes 
strongly accumulated CuO-NPs in a time-, concentration-, temperature- and media-
dependent manner. Results from experiments with pharmacological inhibitors of 
different endocytotic pathways suggest that clathrin-mediated endocytosis, 
macropinocytosis and the recycling of membranes are involved in the uptake of CuO-
NPs by astrocytes. Accumulated CuO-NPs exerted a strong toxicity when the specific 
cellular copper contents reached values above 10 nmol copper per mg protein. The 
mechanism of toxicity was assigned to a strong increase in reactive oxygen species in 
the treated cells. Cultured astrocytes treated with subtoxic concentrations of CuO-NPs 
over a time period of 24 h strongly increased their gycolytic flux, their glutathione 
content as well as the levels of the copper storage protein metallothioneine. The 
observed increase in glycolytic flux and metallothioneine levels was prevented in 
presence of the cell permeable copper chelator tetrathiomolybdate. This chelator was 
also capable of preventing the strong toxicity and the increased generation of reactive 
oxygen species in acute exposure scenarios where high concentrations of CuO-NPs 
were applied to cultured astrocytes. Similarly, toxicity observed after the exposure of 
cultured astrocytes with CuCl2 was prevented by copper chelators while copper 
reducing antioxidants increased copper uptake and copper derived toxicity. 
The data presented in this thesis reveal that CuO-NPs can have severe deleterious 
effects on astrocytes, which otherwise are very robust against several toxins. The 
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vulnerability of astrocytes to CuO-NPs suggests that brain cells may be severely 
damaged if they encounter such nanoparticles. Hence, the exposure of humans to CuO-
NPs should be minimized and carefully evaluated to prevent potential health hazards. 
  
 
9 Zusammenfassung 
IV. Zusammenfassung 
 
Kupferoxid Nanopartikel (CuO-NPs) haben Aufgrund ihrer interessanten 
physikochemischen Eigenschaften unlängst das Interesse der Industrie geweckt. Die 
stetige Zunahme CuO-NP beinhaltender Produkte und die unkontrollierte Freisetzung 
von CuO-NPs steigern das Risiko einer menschlichen Exposition. Da Nanopartikel 
durch eine Exposition in das Gehirn gelangen können, ist es von großem Interesse die 
Aufnahme und potentielle negative Effekte auf Gehirnzellen zu evaluieren. In diesem 
Kontext sind Astrozyten von besonderem Interesse, da ihnen eine zentrale Rolle in der 
Homöostase des Gehirns und in detoxifizierenden Prozessen zugeschrieben wird.  
In der vorliegenden Arbeit wurde eine Methode zur Synthese von CuO-NPs etabliert. 
Nach einer detaillierten Analyse der  physikochemischen Eigenschaften der 
synthetisierten CuO-NPs wurden primäre Astrozytenkulturen mit diesen Partikeln 
behandelt. Die Akkumulation von CuO-NPs durch Astrozyten und der Aufnahmeweg, 
sowie die Effekte von CuO-NPs auf die Vitalität und den Metabolismus der behandelten 
Zellen wurden untersucht. Astrozyten nahmen CuO-NPs in Abhängigkeit von Zeit, 
Konzentration, Temperatur und Inkubationsmedium auf. Unter Zuhilfenahme 
pharmakologischer Inhibitoren verschiedener Endozytosewege wurde eine Beteiligung 
von Clathrin-vermittelter Endozytose, Makropinozytose und Membran Recycling an der 
Aufnahme von CuO-NPs festgestellt. Aufgenommene CuO-NPs übten eine starke 
Toxizität aus, wenn der spezifische zelluläre Kupfergehalt der behandelten Zellen einen 
Wert von 10 nmol Kupfer pro mg Protein überstiegen hat.  Der Mechanismus der 
Zellschädigung wurde der gestiegenen  Produktion reaktiver Sauerstoffspezies 
zugeschrieben. Wurden kultivierte Astrozyzen über einen Zeitraum von 24 Stunden mit 
sub-toxischen Konzentrationen von CuO-NPs behandelt, so steigerten sich deren 
glykolytischer Fluss, deren Glutathiongehalt und deren Menge an den 
Kupferspeicherproteinen Metallothionein. Die gezeigte Steigerung im glykolytischem 
Fluss und in der Menge von Metallothioneinen konnte mittels des membrangängigen 
Kupferchelators Tetrathiomolybdat unterdrückt werden. Dieser Chelator konnte 
ebenfalls die strake Toxizität und gesteigerte Produktion reaktiver Sauerstoffspezies in 
akuten Expositionszenarien, in denen die Zellen mit hohen Konzentrationen von CuO-
NPs behandelt wurde, mindern. In vergleichbarer Weise konnte die toxische Wirkung 
von CuCl2 auf Astrozytenkulturen mittels Kupferchelatoren verringert werden, 
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wohingegen Kupfer-reduzierende Antioxidantien die Kupferaufnahme und Kupfer 
vermittelte Toxizität steigerten. 
Die Daten aus der vorliegenden Arbeit zeigen, dass CuO-NPs bei einer Exposition von 
Astrozyten, welche andernfalls sehr robust gegen Toxine sind, schwerwiegende 
schädliche Effekte hervorrufen können. Die schädigende Wirkung von CuO-NPs auf 
Astrozyten spricht dafür, dass ebenfalls andere Gehirnzelltypen von diesen 
Nanopartikeln beeinträchtigt werden könnten. Demzufolge sollte eine Exposition von 
Menschen mit CuO-NPs minimiert und das Expositionsrisiko mit Sorgfalt abgeschätzt 
werden um mögliche Gesundheitsrisiken zu vermeiden. 
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V. Abbreviations and symbols 
 
Ami   Amiloride 
ARE   Antioxdative response elements  
ATP   Adenosine triphosphate 
BSA    Bovine serum albumin 
CuO-NPs  Copper oxide nanoparticles 
pCuO-NPs   BSA coated CuO-NPs 
CPZ   Chlorpromazine 
CQ   Chloroquine 
Ctr1   Copper transport protein 1 
DMSA  Dimercaptosuccinic acid 
DMSO  Dimethyl sulfoxide 
DMT1   Divalent metal transporter 1 
DNA   Deoxyribonucleic acid 
DMEM  Dulbecco's modified Eagle’s medium 
DMEM-FCS  Dulbecco's modified Eagle’s medium containing 10% FCS 
EU   European Union 
FCS   Fetal calf serum 
GFAP   Glial fibrillary acidic protein  
H33342  Bisbenzimide Hoechst 33342 
HEPES  4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid 
IB   Incubation buffer 
IB-BSA  Incubation buffer containing 0.5 mg BSA per mL  
LDH   Lactate dehydrogenase 
LC3   Microtubule-associated protein 1 light chain 3 
MAP   Mitogen-activated protein 
MRE   Metal response elements  
 
12 Abbreviations and symbols 
MTT   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
Nrf2   Nuclear factor erythroid 2-related factor 2 
PI   Propidium iodide 
PBS   Phosphate buffered saline 
RNA   Ribonucleic acid 
ROS    Reactive oxygen species 
siRNA   Small interfering RNA 
TMP   Tetramethylpyratine 
US   United States 
UV   Ultraviolet 
Wort   Wortmannin  
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1. Introduction 
1.1 Nanoparticles 
1.1.1 Basic concepts 
The history of nanomaterials reaches back thousands of years. Archeologists found that 
already 3000 years ago in Egypt and China gold, silver, platinum and palladium 
nanoparticles were used in paint, even without the knowledge of the existence and the 
properties of these materials (Daniel and Astruc 2004, Heiligtag and Niederberger 
2013). Since the medieval times colloidal gold and silver were used in European 
churches for coloring glass as well as in the glaze of porcelain and other pottery 
(Horikoshi and Serpone 2013). As until the last century no analytical method existed to 
study materials of a size smaller than 1 µm, the knowledge on those materials was 
limited. Nanotechnology is a science that emerged in the beginning of the last century 
by the development of the high resolution microscopy techniques, transmission electron 
microscopy (1932) and scanning electron microscopy (1937), revealing the scale of 1 
billionth of a meter (1 nm = 10
-9
 m) which is the size range of molecules and atoms 
(Knoll and Ruska 1932, von Ardenne 1938). In 1959 Richard Feynman proposed in his 
speech “There’s plenty of room at the bottom” the possibility of the synthesis of 
materials by direct manipulation of atoms (Feynman 1960). Although the term 
nanotechnology was first used by Norio Taniguchi in 1974, it was not until 1982 when 
the scanning tunneling microscope, which was invented by Gerd Binnig and Heinrich 
Rohrer who received a noble prize in 1986, was able to resolve molecular structures and 
atomic bonds (Taniguchi 1974, Binnig and Rohrer 1986). In the year 1989, Donald 
Mark Eigler used the scanning tunneling microscope technique to manipulate individual 
atoms validating the theory of Feynman (Eigler and Schweizer 1990).  
Several new nanomaterials with interesting physical properties were discovered along 
the last 50 years, for example carbon nanofibers (Koyama and Endo 1973), fullerenes 
(Kroto et al. 1985), carbon nanotubes (Iijima 1991) and graphene (Novoselov et al. 
2004). Some of these discoveries were awarded with noble prizes. There are several 
definitions available from different international organizations for the terms 
“nanomaterials” and “nanoparticles” (Table 1.1). Conclusively, it can be said that 
nanoparticles are defined as objects with at least 2 dimensions in the nanoscale (1-100 
nm) and that nanomaterials have an external or internal structures in the nanoscale. 
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Besides the size of nanoparticles, there are many other aspects that have to be 
considered to define nanoparticles (Figure 1.1) (Borm et al. 2006). The chemical and 
physical properties of nanoparticles do not only depend on their size, but also on their 
composition which can be organic (polymers, lipids) as well as inorganic (metal, metal 
oxides, metalloid, metalloid oxides) or a mixture of both (Akhtar et al. 2013, Allouche 
2013, Cupaioli et al. 2014). Also the shape affects the physical properties of 
nanoparticles (Jo et al. 2015). The size of nanoparticles and their shape define their 
surface area (Kettler et al. 2014). In comparison to bigger particles, the surface area of 
smaller particles is higher in relation to their volume. For example, a cube with a side 
length of 1 cm has a surface area of 6 cm
2
. The volume of this cube (1 cm
3
) is equal to 
the volume of 1000 cubes with a side length of 1 mm, whereas the surface area of these 
cubes is in total 60 cm
2
. If the same volume is filled up with cubes of 1 nm side length, 
the total surface area increases to 6•107 cm2. Therefore, the big advantage of 
nanomaterials is that only a low amount of material is required to create a very large 
surface.
 
Figure 1.1: Chemical and physical properties of nanoparticles. 
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The surface of the nanoparticles is an important aspect, which determines the properties 
of the material by defining its catalytic activity/inactivity, the resistance to 
environmental factors, the binding ability to molecules and other surfaces as well as 
interactions with cells (Kettler et al. 2014, Jo et al. 2015). Due to the importance of the 
nanoparticle surface, it is of high interest to improve this surface by optimized synthesis 
or further modification to obtain the desired material properties. The native surface of 
nanoparticles is either charged or uncharged, depending on the used material and the 
synthesis method. Modifications of the surface can be performed by the addition of a so 
called “coating” material. These substances are mostly polar, polymeric or oligomeric 
compounds such as polyethylene glycol, polyvinylpyrrolidone, polyacrylic acid, 
polysorbate or dextran (Sperling and Parak 2010, Amin et al. 2015). These are used to 
give high aqueous dispersity, prevent agglomeration and increase the stability of the 
particles in biological media (Sperling and Parak 2010, Amin et al. 2015). The coating 
of the nanoparticles also allows the introduction of additional compounds to the particle 
surface (Sperling and Parak 2010, Amin et al. 2015). Such modifications could increase 
the catalytic activity of the material or add further features to the nanoparticles (Figure 
1.2), including antibodies, proteins or glycans for cell targeting, or drugs, fluorescent 
dyes, enzymes, DNA and many other (Sperling and Parak 2010, Amin et al. 2015, Kang 
et al. 2015a, Pérez-Herrero and Fernández-Medarde 2015). The possibility to add 
several modifications to the nanoparticle surface makes it even more interesting to build 
tailor-made tools for specific applications. Especially nanomedicine seems to be a 
promising technology for individual and highly specific treatment of patients (Pautler 
and Brenner 2010, Chang et al. 2015). 
Due to the wide variety of different possible combinations of those materials, it is 
unfortunately very difficult for the scientific community and the regulatory 
organizations to unify and simplify regulations, common standards and safety issues of 
nanomaterials (Borm et al. 2006, Cupaioli et al. 2014).  
1.1.2 Nanoparticles in industry, environment and human health 
Over the last decade the amount of nanoparticle-containing consumer products strongly 
increased to a number of above 1,800 products, as listed in the databases “Project on 
emerging nanotechnologies” (Consumer Products Inventory 2015) and “The 
Nanodatabase” (Danish Consumer Council 2015). Approximately the half of the 
registered products was listed into the categories cosmetics and clothing. Although not 
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all registered nanoparticle containing products were analyzed to inform the consumer 
about the ingredients, the most commonly used material for applied nanoparticles was 
silver. Depending on the used material, nanoparticles are used for various technical and 
biomedical applications and can appear in certain products (Table 1.2).  
 
 
 
Figure 1.2: Surface modifications of nanoparticles. Additional features can be 
introduced to nanoparticles by binding of different substances to the surface of 
nanoparticles. Nanoparticles (A) can be modified by introducing antibodies (B), DNA 
(C), drugs (D), proteins or enzymes (E), glycans (F) or fluorescent dyes (G). 
 
The annual production of nanomaterials increases each year and in 2012 reached a value 
of >10,000 tons and is predicted to further increase to an amounts of up to 100,000 tons 
till the year 2020 (Piccinno et al. 2012, Zhang et al. 2015). Therefore, it can be assumed 
that the environment is also increasingly polluted with nanomaterials. In the beginning 
of this century almost nothing was known about the environmental impact of 
nanomaterials (Krug 2014). Before the year 2000 less than 200 papers were published 
on nanotoxicology (Krug 2014). Since then an exponential increase of publications on 
this topic was recorded to a total number greater than 10000 papers (in 2013) (Krug 
2014). 
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The gain of applications of these new products and the increasing production output 
raised awareness of the governments and the scientific community towards the potential 
adverse environmental consequences of this technology (Krug 2014). Unfortunately, 
although a lot of ecotoxicological studies on nanomaterials were performed, the high 
variety of nanomaterials and the strong variation between different test systems makes it 
difficult to give clear statements on the toxicity of these materials (Juganson et al. 
2015). Nevertheless, solid databases might help to predict potential and evaluate the 
ecological impact of nanomaterials (Juganson et al. 2015). Fortunately, several research 
frameworks/clusters were formed to evaluate the potential environmental dangers of 
nanomaterials, for example the EU “NanoSafetyCluster” or the US “National 
Nanotechnology Initiative”. 
Silver nanoparticles are a good example for the impact of nanomaterials on the 
environment. These nanoparticles are increasingly used for functional clothing and can 
strongly leach out of their support material into the environment, polluting sewage 
plants and rivers (Schlich et al. 2013, Zhang et al. 2015). Also copper oxide 
nanoparticles (CuO-NPs), which are used on a big scale in anti fouling paint of ships 
and in wood preservatives, have close contact to the environment and a high chance to 
deposit there (Almeida et al. 2007, Perreault et al. 2012b). Those nanoparticles can 
become extremely toxic to soil and aquatic organisms if the corresponding ions leach 
out of the particles (Bondarenko et al. 2013). Especially for heavy metal containing 
nanomaterials, it is of high interest to understand the interaction of the materials with 
the environment and evaluate the potential risk of an environmental contamination and 
accumulation during the life cycle of these products (Glover et al. 2011, Zhang et al. 
2015). The understanding of the underlying mechanisms of nanomaterial life cycles 
could assist in the creation of sustainable and non-toxic nanomaterials.  
Beside the environmental impact of nanomaterials, substantial amounts of research are 
focused on the question how those materials could directly affect the human health 
(Paur et al. 2011). Due to the widespread applications of nanoparticles (Table 2) the risk 
of an exposure of man to those materials is high. Not only the release of nanoparticles 
into the environment but also the direct contact to nanoparticle-containing products and 
the occupational exposure to such materials could create a risk for the human health that 
has to be assessed. To understand the potential impact of nanoparticles on the human 
health, it is necessary to consider several aspects such as nanoparticle generation and 
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occurrence, nanoparticle characteristics, possible exposure routes, targeted organs and 
effects of those particles on cells and whole organisms. For humans, the primary 
exposure routes for nanoparticles are ingestion and inhalation, whereas the skin is 
hardly penetrated (Borm et al. 2006, Kimura et al. 2012). The majority of airborne 
nanoparticles are incidentally created by the burning of fuels, mechanical abrasion or 
generation of fumes in the metal industry (Borm et al. 2006, Szymczak et al. 2007, 
Balkhyour and Goknil 2010).  
To investigate the toxicity of nanoparticles several test systems and model organisms 
can be used (Frohlich and Salar-Behzadi 2014). Many studies on the toxicity of 
different nanoparticles were carried out in vitro on cultured lung cells (Paur et al. 2011). 
Nevertheless, cell studies have their limitations and cannot mimic the entire organism. 
Therefore, to assess the whole picture of nanoparticle toxicity also in vivo inhalation 
and injection studies are necessary. Considering many comparative in vitro and in vivo 
studies on the potential toxicity of nanoparticles, it was shown that CuO-NPs were 
among the most toxic nanoparticles (Fahmy and Cormier 2009, Cronholm et al. 2013, 
Ivask et al. 2015, Katsnelson et al. 2015).  
1.1.3 Copper oxide nanoparticles 
 
The cheap price and the special features of CuO-NPs led to an increased interest from 
the industry towards this material (Yurderi et al. 2015). Due to their physical properties 
CuO-NPs are excellent electric conductors, making them interesting for microelectronic 
products such as conductive ink or sensor elements (Dharmadasa et al. 2013, Yang et al. 
2015). Another physical property of CuO-NPs is their effective heat conductivity, 
making them efficient additives for heat transfer fluids and lubricants (Ettefaghi et al. 
2013, Manimaran et al. 2014, Jatti and Singh 2015). The cheap price, the high surface 
reactivity and the nanoparticle specific high surface area of this material qualifies CuO-
NPs as cost-effective catalyst for various chemical reactions (White et al. 2006, Yurderi 
et al. 2015). However, despite their high application potential there are various 
disadvantages of this material. The most double edged feature of CuO-NPs is their 
biocidal activity. On the one hand, CuO-NPs are effectively used in anti-fouling paint, 
wood preservatives, sterile surface coatings, water filters or in textiles and bandages 
(Almeida et al. 2007, Evans et al. 2008, Ahmad et al. 2012, Perreault et al. 2012b, Ben-
Sasson et al. 2014, Dankovich and Smith 2014). On the other hand, the biocidal activity 
of CuO-NPs could be unintentionally harmful to the environment and human health 
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(Karlsson et al. 2008). Therefore, close monitoring of the toxic potential of those 
particles is necessary to evaluate their risk.  
To understand the toxic mechanisms of CuO-NPs it is important to elucidate the uptake 
and distribution of such particles in the body. In this context it is important to consider, 
especially for the occupational exposure scenario, that CuO-NPs are unintentionally 
released from electric motors or during welding (Szymczak et al. 2007, Balkhyour and 
Goknil 2010). Airborne CuO-NPs are easily inhaled and can thereby enter the body. In 
vitro studies showed the high toxic potential of CuO-NPs to several lung cell lines 
(Karlsson et al. 2008, Cronholm et al. 2013, Kim et al. 2013, Semisch et al. 2014, 
Ahamed et al. 2015, Ivask et al. 2015, Jing et al. 2015). In vivo inhalation and injection 
studies on mice and rats confirmed this high toxicity (Chen et al. 2006, Liao and Liu 
2012, Privalova et al. 2014, Jing et al. 2015). Interestingly, one of these inhalation 
studies reported that CuO-NPs were more toxic than µm sized copper oxide particles 
(Yokohira et al. 2008). It was also reported that inhaled nanoparticles can enter into the 
blood stream and are also able to cross the blood brain barrier (Kreyling et al. 2002, 
Oberdorster et al. 2004, Sharma and Sharma 2012, Yim et al. 2012). In vivo studies of 
CuO-NPs showed that those particles can accumulate in the brain and have a high 
capacity to alter brain functionality (An et al. 2012, Privalova et al. 2014). So far, only 
very few studies were performed to evaluate the toxicity of CuO-NPs on brain cells (Li 
et al. 2007, Chen et al. 2008, Xu et al. 2009, Prabhu et al. 2010, Liu et al. 2011, 
Perreault et al. 2012a). However, all those studies focused on neuronal cell lines, 
whereas nothing was known about the effect of those particles on astrocytes. 
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1.2 Astrocytes 
 
Brain cells can be classified in general into two types: the signal conducting and 
integrating neuronas and the supportive glial cells. The human brain consists of 
approximately 86 billion neurons and 85 billion glial cells (Herculano-Houzel 2014). 
The neuron to glia ratio differs strongly between certain brain regions (Herculano-
Houzel 2014). In the brain, the glial cell types are divided into microglia, 
oligodendrocytes and astrocytes (Figure 1.3) (Sofroniew and Vinters 2010). Between 
these very differing group of cells, astrocytes are the most abundant cell type 
(Herculano-Houzel 2014). Astrocytes are located between the endothelia cells of the 
brain blood vessels and neurons (Mathiisen et al. 2010, Sofroniew and Vinters 2010). 
Various important functions of the brain homeostasis are attributed to astrocytes, of 
which a few will be described in the following subchapters. After elucidating the key 
role of astrocytes in the brain, it is no surprise that several neurological and psychiatric 
disorders are connected to disturbances in the astrocytic functions (Allaman et al. 2011, 
Rossi 2015, Verkhratsky et al. 2015, Verkhratsky and Parpura 2015, Yamamuro et al. 
2015).  
 
1.2.1 Functions at the synapse 
 
Astrocytes are responsible to maintain the neural plasticity in the developing and mature 
brain (Parpura et al. 2012, Haydon and Nedergaard 2015). They are important 
interacting partners with neurons and are contributing strongly to the genesis, 
maturation and maintenance of the synaptic connectivity (Verkhratsky et al. 2015, 
Verkhratsky and Parpura 2015). Moreover, astrocytes are responsible for the 
homeostasis of neurotransmitters and ions in the synaptic cleft (Verkhratsky et al. 2015, 
Verkhratsky and Parpura 2015). Astrocytes are also able to modulate the synaptic 
transmission by the release of so called gliotransmitters such a glutamate, ɣ-
aminobutyric acid, D-serine, ATP and lactate (Volterra and Meldolesi 2005, Gundersen 
et al. 2015, Verkhratsky et al. 2015, Verkhratsky and Parpura 2015). Due to their 
connection with neurons and their involvement in signal modulation, astrocytes seem to 
be strongly involved in cognition, emotion as well as motoric and sensory processing 
(Oliveira et al. 2015). 
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Figure 1.3: Schematic illustration of the cellular organization in the brain. The signal 
transducing neurons (blue) and their interaction with the major glial cell types such as 
astrocytes (green), oligodendrocytes (purple) and microglial cells (brown) is shown 
(Allen and Barres 2009). Adapted with permission from Macmillan Publishers Ltd: 
Nature, Allen and Barres 2009, "Neuroscience: Glia - more than just brain glue", 
copyright 2009. 
 
1.2.2 Metabolic interactions with neurons 
Neurons also have a tight metabolic interconnection with astrocytes (Pellerin and 
Magistretti 1994, Magistretti 2006, Allaman et al. 2011, Brekke et al. 2015). Astrocytes 
are highly glycolytic and are able to export large amounts of lactate (Pellerin and 
Magistretti 1994, Itoh et al. 2003). Neurons rely on oxidative metabolism and are able 
to use lactate as an oxidative substrate to produce high amounts of ATP (Bélanger et al. 
2011). However, it is still under discussion whether astrocytes export lactate as primary 
energy fuel for neurons (Mangia et al. 2011, Pellerin and Magistretti 2012, Brekke et al. 
2015, Lundgaard et al. 2015). The so called glutamate-glutamine cycle is another 
metabolic pathway which describes the tight metabolic interaction of astrocytes and 
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neurons in the synthesis of neurotransmitters (Brekke et al. 2015). Astrocytes export 
large amounts of glutamine to supply neurons with a precursor for glutamate and ɣ-
aminobutyric acid synthesis, since neurons are unable to synthesize sufficient amounts 
of the neurotrasmitting glutamate and ɣ-aminobutyric acid from glucose (Brekke et al. 
2015). Further, astrocytes supply neurons with glutathione precursors to support 
neuronal glutathione synthesis (Hirrlinger and Dringen 2010, Dringen et al. 2015a). 
 
1.2.3 Detoxification 
Due to the tight coverage of the endothelia cells of the blood capillaries by the 
astrocytic endfeet, astrocytes are the first parenchymal cells of the brain that encounter 
harmful substances that are crossing the blood brain barrier, such as toxins, heavy 
metals or drugs (Mathiisen et al. 2010, Sofroniew and Vinters 2010). Therefore it is of 
high importance that astrocytes are able to handle such compounds. Indeed, astrocytes 
are capable to tolerate and detoxify various toxins, heavy metals and drugs (Scheiber et 
al. 2010, Brandmann et al. 2012, Arend et al. 2013, Tulpule and Dringen 2013, Dringen 
et al. 2015a, Dringen et al. 2015b). Astrocytes have high glutathione contents and a high 
capability to perform glutathione-dependent detoxification processes (Dringen et al. 
2015a). The tripeptide glutathione, which is the major low molecular weight antioxidant 
of cells, is involved in the detoxification of exogenous toxic substances but is also able 
to mitigate endogenously generated oxidants (Dringen et al. 2015a). For example, redox 
active metals like copper can accelerate reactive oxygen species production by 
effectively catalyzing the formation of reactive oxygen species in presence of H2O2 or 
superoxide in Fenton-like reactions (Pham et al. 2013). However, due to the fact that 
astrocytes are able to increase their glutathione contents upon exposure to copper and 
various other potential toxic substances (Dringen et al. 2015a), these cells are 
considered as the central element for detoxification in the brain (Hirrlinger and Dringen 
2010, Schreiner et al. 2015). However, impairment of the astrocytic glutathione 
homeostasis can lead to a severe loss in the tolerance against oxidative stress (Liddell et 
al. 2006, Lee et al. 2010). 
 
1.2.4 Functions in the metal metabolism of the brain 
Metals such as iron and copper are essential for several cellular functions (Liu et al. 
2014). Iron is essential component of iron-sulfur clusters and heme groups in proteins 
(Liu et al. 2014). These groups are required for the electron transport of the respiratory 
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chain and are involved in various other enzymatic processes (Liu et al. 2014). Copper is 
a component of various enzymes which are required for energy metabolism, 
antioxidative defence, iron metabolism and neurotransmitter synthesis (Liu et al. 2014, 
Scheiber et al. 2014).  
The strategic localization of astrocytes at the endothelia cells of the blood capillaries 
and the effective uptake and export capabilities of those cells for iron and copper 
strongly suggests that astrocytes have a central role in the trafficking of those metals to 
other brain cells (Dringen et al. 2007, Scheiber et al. 2014). Despite the essential 
function of both metals, iron and copper can become toxic if they are accumulated at 
higher levels by causing severe generation of reactive oxygen species (Jomova and 
Valko 2011). Therefore, the uptake, storage and export of those metals by astrocytes are 
tightly regulated (Tiffany-Castiglioni and Qian 2001, Dringen et al. 2007, Dringen et al. 
2013, Scheiber et al. 2014). Further, these cells are able to tolerate and sequester excess 
amount of toxic metals and therefore are considered as metal sink of the brain (Tiffany-
Castiglioni and Qian 2001). The role of astrocytes in the copper metabolism of the brain 
was recently reviewed in detail (Dringen et al. 2013, Scheiber et al. 2014). 
 
1.2.5 Astrocytes and nanoparticles 
Several studies were conducted on cultured astrocytes to test for their resistance against 
iron oxide and silver nanoparticles (Geppert et al. 2011, Luther et al. 2011, Hohnholt 
and Dringen 2013, Petters et al. 2014). An overview about these studies was published 
earlier (Hohnholt et al. 2013). Throughout these studies it has been shown that cultured 
astrocytes are not very sensitive to those nanomaterials (Geppert et al. 2011, Luther et 
al. 2011, Hohnholt and Dringen 2013, Petters et al. 2014). These studies also analyzed 
the uptake and storage mechanism with the help of electron microscopy and fluorescent 
molecules which were attached to those nanoparticles (Geppert et al. 2011, Petters et al. 
2014, Petters et al. 2015). In contrast to iron oxide and silver nanoparticles, recent 
studies have shown that cultured astrocytes are sensitive against zinc oxide and titanium 
dioxide nanoparticles and the observed toxicity was correlated to increased oxidative 
stress (Wang et al. 2014, Wilson et al. 2015). Concerning the ability of astrocytes to 
deal with CuO-NPs, no literature data were available at the start of the experimental 
work of the presented thesis. An up to date description how cultured astrocytes deal 
with CuO-NPs and copper which includes most of the data shown in the presented 
thesis is included as chapter 1.3 below. 
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1.4 Aim of the thesis 
 
The aim of this thesis is to investigate the uptake and toxicity of CuO-NPs on cultured 
primary astrocytes. For this purpose, a synthesis method of CuO-NPs will be 
established and the physicochemical properties of those nanoparticles will be 
characterized. Subsequently, CuO-NPs will be applied to cultured primary astrocytes in 
acute and chronic exposure scenarios. The accumulation of CuO-NPs will be evaluated 
by quantification of cellular copper content and the data obtained for CuO-NPs will be 
compared to those for copper ions. In this context, experiments will be performed to 
elucidate the mechanism of nanoparticle uptake. Potential deleterious effects of CuO-
NPs and ionic copper on astrocytes will be investigated and it will be tested if 
compounds like copper chelators and antioxidants can prevent copper mediated toxicity 
in astrocytes. Finally, it will be investigated whether cultured astrocytes respond to a 
treatment with sub-toxic concentrations of CuO-NPs with a stimulation of protective 
mechanisms and with alterations in the cell metabolism. 
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2.4 Endocytotic uptake of CuO-NPs by cultured 
primary astrocytes 
2.4.1 Introduction 
The cellular uptake of nanoparticles can be mediated by different endocytotic pathways 
(Zhang et al. 2009, Iversen et al. 2011). Primary cultured astrocytes are able to 
accumulate iron oxide nanoparticles and silver nanoparticles by macropinocytosis and 
clathrin-mediated endocytosis (Luther et al. 2011, Geppert et al. 2012). In contrast, the 
uptake mechanism for copper oxide nanoparticles (CuO-NPs) into these cells has not 
been reported so far. The experimental data presented in this chapter will elucidate a 
potential contribution of different endocytotic pathways in the uptake of CuO-NPs into 
cultured primary astrocytes by applying inhibitors of different endocytotic pathways.  
2.4.2 Materials and methods 
All materials and chemical used, were purchased from the suppliers given in the 
previous chapters (Chapter 2.1-2.3) or recent publications (Luther et al. 2011, Geppert 
et al. 2012, Petters and Dringen 2015).  
2.4.2.1 Synthesis and characterization of protein coated CuO-NPs 
CuO-NPs were synthesized according to a previously published method (Bulcke et al 
2014 - Chapter 2.1). These particles were coated with bovine serum albumin (BSA). For 
this purpose, a solution of 20 mg per mL BSA was prepared in water and 72.5 µl of this 
solution was mixed with 500 µL CuO-NPs (30-40 mM) for 30 s. The resulting solution 
was mixed with 1 mL of a high salt mixture (200 mM HEPES, 50 mM glucose, 18 mM 
CaCl2, 10 mM MgCl2, 54 mM KCl, 1.45 M NaCl, pH 7.4 at room temperature) for 30 s 
and subsequently centrifuged for 5 min at 12000 g. The resulting supernatant was 
discarded and the remaining pellet containing BSA coated CuO-NPs (pCuO-NPs) was 
redispersed in 500 µL H2O and sonified for 30 s as described previously (Bulcke et al 
2014 - Chapter 2.1). The copper concentration of the resulting pCuO-NP solution was 
determined by atomic absorption spectroscopy as described previously (Bulcke et al 
2014 - Chapter 2.1). Concentrations of pCuO-NPs were given as concentration of the 
total copper present in the pCuO-NP-containing dispersions used and not as particle 
concentrations. The synthesized pCuO-NPs were characterized by dynamic and 
electrophoretic light scattering as described previously (Bulcke et al 2014 - Chapter 
2.1). 
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The hydrodynamic diameter and the ζ-potential of the synthesized pCuO-NP was in 
water 152 ± 9 nm and -35 ± 3 mV (n=3, measurements were kindly performed by 
Arundhati Joshi). When dispersed in in incubation buffer (20 mM HEPES, 5 mM 
glucose, 1.8 mM CaCl2, 1 mM MgCl2, 5.4 mM KCl, 145 mM NaCl, adjusted to pH 7.4 
at 37°C) containing 0.5 mg per mL BSA (IB-BSA), the hydrodynamic diameter pCuO-
NPs slightly increased and the ζ-potential was less negative (165 ± 12 nm; -14 ± 4 mV). 
The synthesized pCuO-NPs had a slightly higher hydrodynamic diameter and less 
negative ζ-potential compared to previously obtained data on non protein coated 
particles (Bulcke et al. 2014 - Chapter 2.1). However, in IB-BSA the pCuO-NPs had 
similar properties as compared to CuO-NPs dispersed in Dulbecco’s modified Eagle’s 
medium (DMEM) containing 10% fetal calf serum (FCS; DMEM-FCS) (Bulcke et al. 
2014 - Chapter 2.1). 
2.4.2.2 Cell culture experiments 
Primary astrocytes cultures were obtained as described previously and seeded in 24-well 
plates (Tulpule et al. 2014). Presence of astrocytes was determined by 
immunocytochemical staining for the astrocytes specific marker glial fibrillary acidic 
protein (GFAP) as described previously (Petters and Dringen 2014). Confocal images 
were taken using a Zeiss LSM 510 META laser scanning microscope equipped with 
argon and helium-neon lasers (Zeiss, Oberkochen, Germany). The 
immunocyotochemical staining for GFAP in the prepared primary cultures confirmed 
the presence of GFAP-positive astrocytes (Figure 2.1).  For incubations, confluent 
primary astrocyte cultures of an age between 14 and 28 days were washed twice with 1 
mL prewarmed (37°C) phosphate buffered saline (PBS; 10 mM potassium phosphate 
buffer, containing 150 mM sodium chloride, adjusted to pH 7.4 at 37°C) and 
subsequently incubated with pCuO-NPs in 1 mL IB-BSA for up to 4 h at 37°C. To test 
for the participation of different endocytotic pathways, the cells were incubated in IB-
BSA with 50 µM pCuO-NPs for 1 h in absence or presence of different endocytosis 
inhibitors. For this purpose, concentrated stock solutions of 200 mM chlorpromazine, 1 
mM wortmannin and 100 mM amiloride were prepared in DMSO and a 100 mM stock 
solution of chloroquine was prepared in water. These concentrated stock solutions were 
diluted in IB-BSA to prepare incubation solutions containing the indicated final 
concentrations of the inhibitors. DMSO in the indicated final concentrations was used as 
solvent control. The endocytosis inhibitors applied have different cellular targets. 
Chloroquin prevents the acidification of vesicles, vesicle fusion and the recycling of 
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membranes (Steinman et al. 1983). Chlorpromazine induces a loss of clathrin from the 
cell membrane and is therefore considered as inhibitor of the clathrin mediated 
endocytosis, whereas wortmannin and amiloride block the cellular macropinocytosis 
(Huth et al. 2006). 
 
 
Figure 2.1: Confocal microscopy image of primary astrocyte cultures stained for the 
astrocyte specific glial fibrillary acidic protein (GFAP). The cell nuclei were stained 
with DAPI (blue), whereas GFAP was immunocytochemical detected with an α-GFAP 
antibody from rabbit and a Cy3 conjugated α-rabbit secondary antibody (red).  
 
Several cellular parameters were investigated after the treatment of the cells with pCuO-
NPs in presence or absence of the inhibitors. The cellular copper and protein content 
were obtained from cell lysates as previously described (Scheiber et al. 2010, Bulcke et 
al. 2014, Tulpule et al. 2014). Briefly, after the treatment, the cells were washed twice 
with PBS and lysed with 400 µL 50 mM NaOH. 100 µL of the generated lysate was 
used to determine the protein content of the cells, whereas another 100 µL of the lysates 
was used for analysis of the cellular copper content (Scheiber et al. 2010, Bulcke et al. 
2014, Tulpule et al. 2014).  
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The viability of the cells was assessed by determination of the activity of cellular 
reductases, the activity of the enzyme lactate dehydrogenase (LDH) and by testing the 
membrane permeability. The reduction capacity of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) was used as indicator for the activity of cellular 
reductases (Mosmann 1983). For this purpose, a modification of a previously published 
method was used (Scheiber et al. 2010, Bulcke et al. 2014). Briefly, after the indicated 
treatments, the cells were incubated with 1 mL MTT in IB-BSA for 90 min at 37°C. 
Subsequently, the media was removed and the cells as well as the generated cellular 
formazan were dissolved in 500 µL DMSO. 20 µL of the DMSO-lysate was mixed with 
180 µL of a mixture of 90% DMSO and 10% 50 mM NaOH in wells of a 96-well plate 
and the absorbance was determined at 540 nm as described previously (Scheiber et al. 
2010, Bulcke et al. 2014). Staining for membrane integrity of the treated cells was 
performed with propidium iodide as previously described (Bulcke et al. 2014, Tulpule 
et al. 2014). The extra- and intracellular activites of the cytosolic enzyme LDH were 
determined as previously described (Bulcke et al. 2014, Tulpule et al. 2014) for 20 µL 
of the incubation media or 20 µL of cell lysates. For obtaining the lysates, the cells were 
washed twice with 1 mL ice cold PBS and subsequently lysed in 1 mL IB-BSA 
containing 1% Triton X-100 for 15 min at 37°C.  
2.4.3 Results 
To test for the accumulation of pCuO-NPs by primary astrocyte cultures, these cells 
were incubated with up to 250 µM pCuO-NPs in IB-BSA for up to 4 h and their MTT 
reduction capacity, their LDH activity, protein content and copper content were 
determined (Figure 2.2). Incubations of primary astrocytes with pCuO-NPs did not 
increase the extracellular LDH activity (Figure 2.2 A). The cellular LDH activity was 
determined as additional indicator for cell viability (Figure 2.2 B). The presence of 
pCuO-NPs led to a time- and concentration-dependent decrease in the cellular LDH 
activity. After 1 h of treatment only the highest concentration of pCuO-NPs applied 
(250 µM) significantly decreased the cellular LDH activity (Figure 2.2 B). Longer 
incubation periods led to a significant decrease of the LDH activity in concentrations 
above 100 µM pCuO-NPs. After 4 h almost no cellular LDH activity was detectable if 
pCuO-NPs had applied in concentrations above 100 µM (Figure 2.2 B). The loss in cell 
vitality was also mirrored in the MTT reduction capacity of the cells but with an earlier 
onset of imparired reduction capacity (Figure 2.2 D).  
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Figure 2.2: Time dependent accumulation of CuO-NPs. Primary astrocytes were 
incubated with up to 250 µM CuO-NPs in IB-BSA for up to 4 h. Extracellular (A) and 
cellular LDH activity (B), the specific cellular copper contents (C) and MTT reduction 
capacity (D) were determined. Significance of differences was analyzed between the 
absence or presence of CuO-NPs in the indicated concentrations (n=3; ANOVA; 
*p<0.05; **p<0.01; ***p<0.001).   
 
However, even in the absence of pCuO-NPs (control condition) a loss in the MTT 
reduction capacity of 45% was detected in the after an incubation time of 4 h in 
comparison to the initially obtained values (Figure 2.2 D). Already after 30 min of 
treatment with 100 µM pCuO-NPs the MTT-reduction capacity of the treated cells was 
significantly reduced by 25% (Figure 2.2.D). Increasing incubation time or 
concentration of pCuO-NPs led to an increased loss in MTT reduction capacity (Figure 
2.2 D). The Specific cellular copper content of the treated cells increased in a time- and 
concentration-dependent manner (Figure 2.2 C). However, all treatments which resulted 
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in specific cellular copper contents higher than 10 nmol copper per mg protein (Figure 
2.2 C) led to a decreased MTT reduction capacity (Figure 2.2 D). 
To analyze the endocytotic uptake mechanisms of pCuO-NPs in cultured primary 
astrocytes, sub-toxic conditions had to be defined in which a sufficient amount of 
copper was accumulated by the treated cells. After 1 h of treatment the cells 
accumulated 10.9 ± 1.2 nmol copper per mg protein when treated with 50 µM pCuO-
NPs, which is approximately a 10-fold higher copper content in comparison to cells 
which had been treated in the absence of pCuO-NPs (0.7 ± 0.1 nmol copper per mg 
protein) (Figure 2.2 C). This amount of accumulated copper appears sufficient to 
manipulate the pCuO-NP uptake with inhibitors. For this incubation condition the cell 
vitality was not compromised. At least no loss in cellular LDH activity was determined 
for incubations of astrocytes for 1 h with 50 µM pCuO-NPs (Figure 2.2 B). Previously 
it was reported, that the extracellular activity of the enzyme LDH might be severely 
inhibited in presence of excess amount of copper (Lai and Blass 1984). To verify if 50 
µM pCuO-NPs can interfere with the determination of the LDH activity cell lysates 
were incubated for 1 h with 50 µM pCuO-NPs. The determined activity of LDH was not 
different in comparison to the initially obtained values (data not shown). Therefore, the 
extracellular LDH activity can also be used in presence of 50 µM pCuO-NPs as reliable 
indicator for cell viability. However, it was not tested if higher concentrations of pCuO-
NPs affect the activity of LDH. The treatment of astrocytes with 50 µM pCuO-NPs did 
not increase the extracellular LDH activity (Figure 2.2 A). A significant decrease in the 
MTT-reducticon capacity of the incubated cells by 25 ± 8% was found after the 
treatment with 50 µM pCuO-NPs compared to incubations performed in the absence of 
pCuO-NPs. As the MTT reduction capacity of the cells is a very early indicator for 
impaired cell vitality and the cellular LDH activity is a very late indicator (Hohnholt et 
al 2015), an additional method was applied to verify vitality of the astrocytes treated 
with 50 µM pCuO-NPs for 1 h. For this purpose a staining for membrane integrity was 
performed (Figure 2.3). The number of cells per well, as determined by the positive 
signal for the membrane permeable DNA-stain H33342 was similar for all treatments 
(Figure 2.3 E-H). The PI staining for membrane integrity of cultured astrocytes revealed 
that no impairment of the astrocytic membranes was observed in the absence of pCuO-
NPs (Figure 2.3 A), while treatment of the cells with 100 µM silver nitrate, which was 
used as positive control for toxicity (Luther et al 2011), showed that each cell was PI-
positive (Figure 2.3 B). The strong signal for PI under these conditions was 
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accompanied by a strong background (Figure 2.3 B). PI-positive cells were not 
observed when the cells were treated with 50 µM pCuO-NPs (Figure 2.3 C). In contrast, 
an increased number of PI-positive cells could be determined if the cells were treated 
with 100 µM pCuO-NPs (Figure 2.3 D).  
 
Figure 2.3: Staining for membrane integrity of pCuO-NP-treated astrocytes. Primary 
astrocyte cultures were incubated for 1 h in the absence or presence of 50 µM or 100 
µM pCuO-NPs in IB-BSA. Subsequently, the membrane integrity of the treated cells 
was determined by propidium iodide staining (A-D). Cell nuclei were stained with 
H33343 (E-H). 100 µM AgNO3 was used as positive control for impaired membranes 
(B) (Luther et al. 2011). The scale bar in panel A applies to all panels. 
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These data verifiy that astrocytes that had been treated for 1 h with 50 µM pCuO-NPs 
accumulated substantial amounts of copper (Figure 2.3 C) whereas the vitality of those 
cells was not compromised (Figure 2.2; Figure 2.3 A,B,D). 
These conditions were chosen to test for the inhibition of endocytotic pathways by 
different endocytosis inhibitors (Table 2.1). Cultured astrocytes were treated in presence 
of 50 µM pCuO-NPs for 1 h in the absence or presence of either 1 mM chloroquine, 20 
µM chlorpromazine, 100 nM wortmannine, 1 mM amiloride or a combination of those 
inhibitors. The extracellular LDH activity was not impaired in any of the chosen 
conditions. The MTT reduction capacity of some conditions was reduced to some 
extend in comparison to the control condition (Table 2.1). However, already treatment 
with DMSO alone led to a decrease of the MTT reduction capacity by 10%. For 
example, in comparison to the vehicle control (water) chloroquine showed a decreased 
MTT reduction capacity of 82 ± 7%. Stronger decreases in the MTT-reduction capacity 
were observed in the combinations of chlorpromazine and wortmannin as well as 
chloroquine and amiloride (Tavle 2.1). Staining for membrane integrity with propidium 
iodide was performed to confirm the viability of the cells treated in presence of 50 µM 
pCuO-NPs and in presence of the inhibitors chloroquin, chlorpromazine and amiloride 
(Figure 2.4). After these treatments, the number of cell nuclei, as determined by H33342 
staining, was not altered compared to control conditions (Figure 2.4 F-J). As shown 
previously (Figure 2.3 B), the application of silver nitrate severely increased the number 
of PI-potive cells (Figure 2.5 B). The membrane integrity of all cells treated in presence 
of pCuO-NPs and of one of the applied endocytosis inhibitors was not affected by the 
treatment, as demonstrated by the absence of PI positive cells (Figure 2.4 C-E). Also the 
combined application of chloroquine and amiloride in presence of pCuO-NPs only led 
to the occurance of a few PI-positive cells (data not shown). The endocytosis inhibitors 
alone did not lead to the occurrence of PI-positive cells during incubation in the absence 
of pCuO-NPs (data not shown). After exposure to 50 µM pCuO-NPs, astrocytes had 
accumulated 10.7 ± 1.2 nmol copper per mg protein at 37°C (Table 2.1). Strong 
inhibition of the active copper accumulation was determined for incubations performed 
at 4°C (5.9 nmol copper per mg protein). To calculate the internalized copper (Figure 
2.5), the extracellular attached copper, which was assumed from the copper values 
obtained at incubations performed at 4°C (Table 2.1) was substracted from the cellular 
copper content obtained at incubations performed at 37°C (Table 2.1).   
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Figure 2.4: Staining for membrane integrity of astrocytes treated with pCuO-NP and 
endocytosis inhibitors. Primary astrocyte cultures were incubated for 1 h with 50 µM 
pCuO-NPs in IB-BSA in absence (A,F) or presence of 100 µM AgNO3, 1 mM 
chloroquine (CQ), 20 µM chlorpromazine (CPZ), or 1 mM amiloride (Ami). 
Subsequently, the membrane integrity of the treated cells was determined by propidium 
iodide staining (A-E). Cell nuclei were stained with H33343 (F-J). The AgNO3 
treatment was used as positive control to impair cell membranes (B) (Luther et al. 
2011). The scale bar in panel A applies to all panels. 
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Figure 2.5: Inhibition of endocytotic CuO-NP uptake. Cultured astrocytes were 
incubated for 1 h in the presence of 50 µM CuO-NPs without (100%; solid line; 10.7 ± 
1.2 nmol copper per mg protein) or with 1 mM chloroquine (CQ), 20 µM 
chlorpromazine (CPZ), 100 nM wortmannin (Wort), 1 mM amiloride (Ami) or the 
indicated combinations of inhibitors. Subsequently, the specific cellular copper contents 
were determined (Table 2.1). Copper values derived form incubations performed at 4°C 
(0%; 5.9 ± 0.5 nmol copper per mg protein) were substracted from the copper values 
obtained at 37°C to calculate the internalized copper. The relative inhibitory effect on 
the internalization of pCuO-NP by the indicated compounds was calculated in 
comparison to the respective control. Asterisks indicate the significance of differences 
of data obtained from cells treated with the given endocytosis inhibitors and the 
respective solvent control (ANOVA; **p<0.01; ***p<0.001). 
 
Under the chosen conditions the inhibitors chloroquin and amiloride showed the highest 
effect and decreased the amount of actively accumulated copper to 39 ± 21% and 19 ± 
8% without severe decreases in cell viability (Table 1; Figure 2.4). Chlorpromazine also 
lowered the copper accumulation to 53 ± 7%. The inhibitors wortmannin and the 
different combinations of endocytosis inhibitors did not effectively lowered the copper 
accumulation or severely decreased the MTT-reduction capacity. 
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2.4.4 Discussion 
The presented data shows that pCuO-NPs are taken up in a time-, concentration-, and 
temperature-dependent manner. These results confirm previously obtained data which 
reported the uptake of CuO-NPs (Bulcke et al. 2014 - Chapter 2.1). However, in 
contrast to the non -protein coated CuO-NPs the pCuO-NPs seem to be more efficiently 
taken up and show higher toxicity. For example incubations with 100 µM CuO-NPs for 
6 h in DMEM-FCS were necessary to obtain copper values around 10 nmol copper per 
mg protein (Bulcke et al. 2014 - Chapter 2.1), whereas in this study the same amount of 
copper was obtained after 1 h treatment with 50 µM pCuO-NPs in IB-BSA. This might 
relate to the protein content of the media, which contained 10% FCS in the case of non 
protein coated CuO-NPs, in contrast to the 0.5 mg BSA per mL used in the presented 
results. Previous experiments with iron oxide nanoparticles revealed that those particles 
are taken up by cultured astrocytes depending on the protein content of the media 
(Geppert et al. 2012). Hereby it was reported, that increasing concentrations of protein 
in the incubation media decreased the cellular nanoparticle accumulation (Geppert et al. 
2012). The time- and concentration-dependent accumulation of pCuO-NPs by 
astrocytes corresponded to a decrease in cell vitality, which was determined by a loss of 
cellular LDH activity and MTT-reduction capacity as well as increased membrane 
permeability. If the specific cellular copper contents exceeded a threshold of 10 nmol 
copper per mg protein a decrease in the cell viability was observed, confirming 
previously obtained data (Bulcke and Dringen 2015 - Chapter 1.3). 
Different pharmacological inhibitors of endocytosis were tested for their potential to 
inhibit the accumulation of CuO-NPs by astrocytes. Several vitality assays were applied 
to test for the viability of the cells treated in presence of pCuO-NPs and the inhibitors. 
Throughout the different incubation conditions no increase in the extracellular LDH 
activity was observable. Altough the extracellular LDH activity was not affected under 
those conditions, a significant drop in the MTT reduction capacity of 27% was 
determined in cells treated with chloroquine or chlorpromazine in the presence of 
pCuO-NPs. Nevertheless, both substances were already shown to decrease MTT 
reduction capacity in astrocytes whereas other vitality assays, such as WST-1 reduction, 
were not affected by chloroquin and chlorpromazine (Berridge and Tan 1993, Isobe et 
al. 1999). Endocytosis was reported to be involved in the cellular uptake of MTT (Liu et 
al. 1997). Therefore, an impaired uptake of MTT can result in a loss of signal in MTT-
reduction capacity of cells treated with endocytosis inhibitors. To rule out that the drop 
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in MTT-reduction capacity originated from non-viable cells, an additional vitality assay 
was performed. The staining for membrane integrity with propidium iodide confirmed 
the viability of the treated cells. To sum it up, the treatment of astrocytes with 50 µM 
pCuO-NPs for 1 h in presence of either chloroquin, chlorpromazine or amiloride did not 
affected the viability of the treated cells. Therefore, a decreased copper content of the 
cells treated under those condtions can be attributed the inhibition of the respective 
endocytotic pathway.  
The copper accumulation of pCuO-NP treated astrocytes was effectively prevented by 
amiloride, chloroquin and chlorpromazine (Figure 2.5). Figure 2.6 summarizes the 
proposed endocytotic mechanisms for the uptake of pCuO-NPs by cultured astrocytes, 
which were determined by the respectice inhibitors.  
 
 
Figure 2.6: Proposed endocytotic uptake mechanisms of CuO-NPs in cultured 
astrocytes. Pharmacological inhibition of clathrin-mediated endocytosis with 
chlorpromazine, macropinocytosis with amiloride and membrane recycling with 
chloroquine effectively lowered the internalization of CuO-NPs in cultured astrocytes. 
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Amiloride was among the tested inhibitors the most potent inhibitor of pCuO-NP 
internalization by astrocytes, reducing the internalized copper by 80%. Amiloride is an 
effective inhibitor of macropinocytosis which also strongly inhibited the accumulation 
of silver nanoparticles in cultured astrocytes (Luther et al. 2011). The pharmacological 
inhibition of macropinocytosis with amiloride revealed that macropinocytosis is the 
predominant pathway for the uptake of TiO2-Nanoparticles in U373 human glial cells 
(Huerta-García et al 2015). The inhibitor of vesicle fusion and membrane cycling 
chloroquine (Steinman et al. 1983) effectively lowered the internalization of pCuO-NPs 
into astrocytes. It was reported that the accumulation of silver nanoparticles could be 
strongly prevented with chloroquine (Luther et al 2011).  The inhibition of the clathrin-
mediated endocytosis with chlorpromazine (Huth et al 2006, Vercauteren et al. 2010) 
lowered the internalization of pCuO-NPs. It was reported that the accumulation of iron 
oxide nanoparticles and silver nanoparticles by astrocytes could be effectively 
prevented by chlorpromazine (Luther et al 2011, Geppert et al 2012).  
The applied pCuO-NPs seem to be accumulated into primary astrocyte cultures by 
similar endocytotic pathways as iron oxide nanoparticles and silver nanoparticles 
(Luther et al. 2011, Geppert et al. 2012). Nevertheless, due to the effective inhibition of 
pCuO-NP uptake with inhibitors of different endocytosis pathways, it seems that not an 
individual pathway is responsible for uptake of pCuO-NPs. In addition, if one uptake 
route is inhibited other mechanisms might participate stronger in the uptake of pCuO-
NPs (Huth et al. 2006, Vercauteren et al. 2010). However, results obtained with 
pharmacological inhibitors of endocytosis have to be evaluated carefully, as the 
specificity of those is poor (Vercauteren et al. 2010, Ivanov 2014). Other methods of 
inhibition, such as RNA interference should be considered for further approaches to 
elucidate the role of individual endocytotic pathways in the uptake of pCuO-NPs. 
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3. Summarizing Discussion 
3.1 Synthesis and characterization of copper oxide 
nanoparticles 
The CuO-NPs used in this study were synthesized by an alkaline precipitation method, 
which is a modification of a published method (Kobayashi et al. 2011). In this 
preparation procedure copper nitrate was precipitated at 75°C by the addition of sodium 
hydroxide under the formation of copper hydroxide (Reaction 1). In a further reaction 
(Reaction 2) copper hydroxide eliminates water at 75°C and generates copper oxide in a 
nanosized form (Chapter 2.1).  
Reaction 1:   Cu(NO3)2 + 2 NaOH  Cu(OH)2 + 2 Na
+
 + 2 NO3
-
 
Reaction 2:              Cu(OH)2   CuO + H2O 
Subsequently, the coating material dimercaptosuccinic acid (DMSA) was added to the 
nanoparticles to facilitate the colloidal dispersion of those. The negatively charged 
carboxyl groups of DMSA can bind to the surface of the CuO-NPs. Further, oxidation 
of the thiol groups of the DMSA results in the formation of disulfide bridges between 
individual DMSA molecules, stabilizing the coat formation by generating a cage-like 
structure (Fauconnier et al. 1997). DMSA is an ideal coating material due to the strong 
binding to the surface of the particles and the intermolecular linking of DMSA 
molecules (Fauconnier et al. 1997). DMSA also has the advantage to be highly 
biocompatible and is frequently used in heavy metal chelation therapy (Brandt et al. 
2015). Additionally, DMSA was already used as coating material for iron oxide 
nanoparticles, which were thoroughly investigated for their effect on brain cells 
(Geppert et al. 2011, Hohnholt et al. 2011, Petters and Dringen 2014, Petters et al. 2014, 
Petters and Dringen 2015, Petters et al. 2015). Those iron oxide nanoparticles were not 
toxic to astrocytes (Geppert et al. 2011, Petters et al. 2014). The DMSA coating 
material can be easily modified by the addition of fluorescent dyes to the thiol groups, 
which allows the subcellular localization of those particles (Luther et al. 2013, Petters 
and Dringen 2014). Thus, DMSA has several advantages as coating material for 
nanoparticles. Other substances such as antibodies, glycans or drugs can be easily 
introduced to the DMSA coat to add further functionality to the particles. 
75°C 
75°C 
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Various other methods are available to synthesize CuO-NPs, which might harvest 
smaller, more uniform or more stable particles (Lignier et al. 2012). The advantage of 
the synthesis method established in the presented thesis is the easy procedure that 
requires no special equipment and no organic solvents, while highly reproducibile 
results were generated (Chapter 2.1). 
For a detailed analysis of nanoparticle properties it is necessary to use several methods 
to get an overview about the particle composition, size, shape, state of agglomeration, 
stability and surface charge (Kettler et al. 2014). Knowing the properties of 
nanoparticles will also help to predict the potential behavior of these nanoparticles 
under certain environmental conditions (Nel et al. 2006, Nel et al. 2009). Effects of 
nanoparticles on organisms, for example toxicity or bioavailability, can already strongly 
differ if only one property of the material is altered. This was clearly shown for 
differently sized CuO-NPs (Karlsson et al. 2009), for differently charged polystyrene 
nanoparticles (Walczak et al. 2015), for nanoparticles with different core materials but 
otherwise same properties (Kim et al. 2014) and for CuO-NPs with different shapes (Di 
Bucchianico et al. 2013).  
The synthesized CuO-NPs were characterized with different analysis methods (Chapter 
2.1). Electron microscopy revealed that CuO-NPs are present in agglomerates in which 
the individual spherical primary particles had a crystalline structure and a size between 
5-10 nm. Electron dispersive X-ray spectroscopy was used to obtain the elemental 
composition of the synthesized CuO-NPs. The elemental analysis revealed that the 
atomic composition of the particles was 54% for copper and 46% for oxygen. Dynamic 
light scattering reavealed an average hydrodynamic diameter of 136 ± 4 nm for CuO-
NP-agglomerates determined in water. The size distribution of the particles in water was 
moderately polydisperse with a polydispersity index of 0.15 ± 0.01. In water, the ζ-
potential of the DMSA-coated CuO-NPs was -49.0 ± 7.2 mV, indicating that the 
negatively charged carboxyl groups of the DMSA are exposed on the nanoparticle 
surface. However, uncoated nanoparticles had a positive surface charge of 35 ± 1.3 mV, 
suggesting that the negatively charged DMSA binds via electrostatic interactions to the 
surface of the positively charged bare CuO-NPs during the coating procedure. 
The physico-chemical properties of CuO-NPs synthesized for this work, delivered a 
concise collection of information on the particles. This dataset allows the comparison of 
the results obtained from this work to others. However, due to different methods used 
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for CuO-NPs synthesis and differing particle properties throughout scientific 
publications, such comparisons have to be conducted carefully. 
The stability of CuO-NPs, in regard to the alteration of physico-chemical properties of 
those particles, is an important factor to consider for the application of such particles in 
biological systems. CuO-NPs can dissolve over time, which might cause problems as 
the liberation of copper ions could interfere with the interpretation of experimental data 
obtained from biological test systems (Studer et al. 2010, Semisch et al. 2014). The 
CuO-NPs used in the presented thesis were stable in aqueous dispersion for up to two 
weeks after the preparation (Table 3.1; Chapter 2.1). Also other studies have reported 
that the colloidal stability of CuO-NPs is not very high in several media (Fedele et al. 
2011, Son et al. 2015). In this context, especially protein free media with high ionic 
strengths causes accelerated formation of agglomerates ultimately resulting in particle 
precipitation (Fedele et al. 2011, Son et al. 2015). 
Table 3.1: Characterization of the synthesized CuO-NPs in different dispersants. 
 
Dispersant 
Hydrodynamic 
diameter (nm) 
Zeta potential 
(mV) Reference 
CuO-NPs Water 136   ± 4 -49 ± 7 Chapter 2.1 
 IB  957   ± 246 -27 ± 9 Chapter 2.1 
 DMEM-FCS  178  ± 12 -10 ± 3 Chapter 2.1 
pCuO-NPs Water  152  ± 9 -35 ± 3 Chapter 2.4 
 IB-BSA  165  ± 12 -14 ± 4 Chapter 2.4 
CuO-NPs and protein coated CuO-NPs (pCuO-NPs) were dispersed in the indicated 
media and their hydrodynamic diameter and zeta potential were determined (n=3). The 
dispersants were water, incubation buffer (IB), incubation buffer containing 0.5 mg 
BSA per mL (IB-BSA) or Dulbecco's Modified Eagle Medium containing 10% fetal 
calf serum (DMEM-FCS). The detailed formulation of the media is given in Chapter 2.1 
and 2.4. 
 
Derjaguin, Landau, Vervey, and Overbeek (DLVO) developed in the beginning of the 
1940s a theory on the stability of colloidal solutions (Derjaguin and Landau 1941, 
Verwey and Overbeek 1948). The DLVO theory describes the force between charged 
surfaces by the combination of the attractive van der Waals force and the electrostatic 
repulsion. Colloidal stability is given, when the electrostatic repulsion of the 
nanoparticle surfaces is higher than the attraction by the van der Waals forces. 
However, if high salt concentrations are present in such dispersions, the electrostatic 
repulsion decreases to such an extent that the sum of the repulsive and attractive forces 
benefits the attraction of the particles (Derjaguin and Landau 1941, Verwey and 
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Overbeek 1948). The particles agglomerate under such circumstances, and if a certain 
agglomeration state is reached, the stability of the colloidal dispersion is impaired and 
subsequently the particles precipitate (Derjaguin and Landau 1941, Verwey and 
Overbeek 1948). The DLVO theory explains the observed agglomeration of CuO-NPs 
in high ionic strength media, as seen in the dispersion of CuO-NPs in IB (Table 3.1). 
Interestingly, in the case that proteins were present in the dispersion media no 
precipitation of the CuO-NPs was observed (Table 3.1), as also reported by others (Xu 
et al. 2012, Miao et al. 2015). Proteins seem to stabilize CuO-NPs (Xu et al. 2012, Miao 
et al. 2015), most likely by an interaction with the charged surface of nanoparticles and 
binding via electrostatic interactions to form a so called “corona” (Nel et al. 2009, 
Treuel et al. 2015). The formation of protein coronas around nanoparticles will of 
course alter the surface properties of those particles (Nel et al. 2009). For example, the 
hydrodynamic diameter of CuO-NPs used for this work increased in presence of 10% 
fetal calf serum by 30%, while the strong negative surface charge of those particles was 
reduced from -49 mV to -10 mV (Table 3.1). Similarly, the ζ-potential of the BSA 
coated pCuO-NPs, which were dispersed in BSA containing incubation buffer, was less 
negative than pCuO-NPs which were dispersed in water, whereas the hydrodynamic 
diameters were comparable in both conditions (Table 3.1). Because the surface 
properties of nanoparticles determine characteristics like bioavailability and toxicity in 
biological systems, it is of high importance to keep track of such phenomena (Lynch et 
al. 2009, Tenzer et al. 2013, Treuel et al. 2015). The formation of protein coronas on 
nanoparticles is inevitable in biological systems in which proteins are always present 
(Treuel et al. 2015). The dynamic process of the protein corona formation and the 
corona itself can be highly variable in presence of multiple proteins (Monopoli et al. 
2012). To circumvent potential problems of this highly variable condition it might be 
beneficial to coat nanoparticles with defined proteins like serum albumins (Röcker et al. 
2009), as done for this work (Chapter 2.4). However, even after the formation of the 
protein corona it can be dynamically altered by an exchange of proteins (Röcker et al. 
2009, Walczyk et al. 2010). This implies for CuO-NPs, that a rapid alteration of the 
surface characteristics occurs if those particles encounter biological environments in 
which their will imidiately interact with surrounding substances. This is of special 
interest regarding the uptake of nanoparticles by for example humans. 
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3.2 Uptake of copper oxide nanoparticles by astrocytes 
Several studies on cultured primary astrocytes reported the ability of astrocytes to 
accumulate different types of nanoparticles (Geppert et al. 2011, Luther et al. 2011, 
Petters et al. 2014, Wang et al. 2014, Wilson et al. 2015). A detailed overview of 
different types of nanoparticles, which were tested for their interaction with astrocyte 
cultures, was recently published (Hohnholt et al. 2013). However, at the start of this 
PhD project no no literature data was available on how cultured astrocytes are affected 
by an exposure to CuO-NPs. To investigate the uptake and potential toxic action of 
CuO-NPs, which were synthesized and characterized as described above, we applied 
those CuO-NPs on primary astrocytes cultures (Chapter 2.1; Chapter 2.2; Chapter 2.4). 
Primary astrocyte cultures accumulated those particles in a time-, concentration- and 
temperature-dependent manner (Chapter 2.1; Chapter 2.2; Chapter 2.4). However, 
strong differences in the amount of copper accumulated by astrocytes were observed for 
protein free CuO-NPs and CuO-NPs that had been coated with BSA prior to the 
incubation. Additionally the incubation media strongly affected the accumulation of 
CuO-NP (Chapter 2.1, Chapter 2.4). The specific copper contents of astrocytes treated 
with 50 µM BSA coated CuO-NPs was 10.7 ± 1.2 nmol copper per mg protein when the 
incubation was performed for 1 h in incubation buffer containing 0.5 mg BSA per mL 
(Chapter 2.4). In a different incubation scenario with with non protein coated CuO-NPs 
and a treatment of the cells DMEM containing 10% FCS, astrocytes accumulated 9.4 ± 
0.7 nmol copper per mg protein after a treatment with 100 µM CuO-NPs  for 4 h 
(Chapter 2.1; Chapter 2.2). As described in the previous chapter, the formation of a 
protein corona around the nanoparticles strongly affects the properties of those particles. 
CuO-NPs seem to be taken up differently by astrocytes depending on the concentration 
and composition of proteins present in the incubation media, as it was already shown for 
the accumulation of iron oxide nanoparticles by astrocytes (Geppert et al. 2012). The 
altered ζ-potential of the particles (Table 3.1) might contribute to the observed 
facilitated accumulation of CuO-NPs in BSA containing incubation media. As discussed 
before, the composition of the protein corona can also substantially contribute to 
differences in the uptake of nanoparticles (Nel et al. 2009).  
The specific cellular copper contents of astrocytes after exposure to CuO-NPs for 3 h, 
were significantly higher in comparison to the specific cellular copper contents of 
astrocytes exposed to similar concentrations of the copper salts CuCl2 and Cu(NO3)2 
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(Chapter 2.1). However, the internalized copper content was similar for CuO-NPs and 
copper salts (Chapter 2.1). This hints to the different mechanisms which seem to be 
involved in the uptake of nanosized and ionic copper. Chapter 1.3 describes in detail the 
proposed uptake mechanisms of CuO-NPs and copper ions by cultured astrocytes (for 
an overview see Figure 3.1). 
 
 
Figure 3.1: Uptake of CuO-NPs and ionic copper by astrocytes. The uptake of CuO-
NPs is mediated by endocytosis, whereas ionic copper is accumulated copper 
transporter Ctr1 and the divalent metal transporter 1 (DMT1). The endocytotic 
mechanisms responsible for the uptake of CuO-NPs were identified with the help of 
pharmacological inhibitors. Vesicles containing internalised CuO-NPs will undergo the 
lysosomal pathway, where copper ions are liberated and exported via Ctr1 or DMT1 
into the cytosol. The uptake of ionic copper by Ctr1 and DMT1 is facilitated by an 
extracellular reduction of Cu
2+
 to Cu
+
, which is catalysed by ectocuprireductases or 
presence of reducing substances such as ascorbate. Application of extracellular copper 
chelators effectively prevented the accumulation of ionic copper. Adapted with kind 
permission from Springer Science+Business Media: Neurochemical Research, Bulcke 
and Dringen 2015, “Handling of Copper and Copper Oxide Nanoparticles by 
Astrocytes”, Figure 1, copyright 2015. 
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The inhibition of different endocytotic pathways suggests that CuO-NPs are taken up by 
cultured astrocytes via endocytotic mechanisms, which involve the acidification, fusion 
and recycling of vesicles, as well as clathrin-mediated endocytosis and 
macropinocytosis (Chapter 2.4, Steinman et al. 1983, Huth et al. 2006). The 
experimental inhibition of the vesicle acidification and membrane recycling with 
chloroquin as well as the inhibition of macropinicytosis with amiloride reduced the 
amount of actively accumulated copper by 61 ± 21% and 81 ± 7%, respectively. A less 
but also significant reduction in the active copper accumulation by approximately 47% 
was obtained by the inhibition of clathrin mediated endocytosis with the inhibitor 
chlorpromazine (Chapter 2.4). However, complete inhibition of active copper 
accumulation, as seen in incubations performed at 4°C, could not be achieved, hinting 
towards a contribution of multiple endocytotic processes in the uptake of CuO-NPs by 
astrocytes (Figure 3.1). Comparable results for the inhibition of nanoparticles 
accumulation were reported previously for silver nanoparticles and ironoxide 
nanoparticles (Luther et al. 2011, Geppert et al. 2012), as discussed previously (Chapter 
2.4).  
In contrast to CuO-NPs, ionic copper can be transported into astrocytes by the copper 
transporter Ctr1 and by the divalent metal transporter 1 (Scheiber et al. 2010, 2014). 
The transport of copper was strongly accelerated when the applied Cu
2+
 was reduced to 
Cu
+
 in presence of reducing agents such as ascorbate or other antioxidants, 
demonstrating the preference of those transporters for Cu
+
 (Chapter 2.3). The 
application of extracellular copper chelators prevented the uptake of ionic copper even 
in the reduced form (Chapter 2.3). Despite the different mechanisms involved in the 
uptake of CuO-NPs or copper ions (Figure 3.1), the accumulated copper dramatically 
affected the viability of the exposed cells, as described in the next chapters. 
3.3 Toxicity of copper and copper oxide nanoparticles on 
astrocytes 
Several cell parameters were investigated to obtain a concise knowledge on the toxic 
effects of CuO-NPs. Hereby it was shown that the different methods used provide 
readings at different stages of toxicity (Chapter 2.3). The reduction capacity of the dye 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) by copper-
exposed astrocytes appears to be the earliest indicator of toxicity (Chapter 2.3). This 
method provides an insight into the activity of cellular reductases which are responsible 
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for the reduction of MTT, although the detailed mechanisms involved in the cellular 
reduction of MTT are so far not elucidated (Stockert et al. 2012). Nevertheless, the 
determination of the cellular MTT reduction capacity gives an idea about the metabolic 
state of the cell which does not necessarily account for a loss in cell viability (Riss et al. 
2013). Methods which determine later stages of toxicity test for the integrity of the 
cellular membranes by investigating the permeability of those for dyes or enzymes 
(Hohnholt et al. 2015). In the presented thesis it is shown, that staining cells with 
propidium iodide and determining the activity of the cytosolic enzyme lactate 
dehydrogenase are reliable indicators for cell death (Chapter 2.1-2.4). However, 
determining the activity of enzymes can strongly be affected by the presence of copper, 
as copper is a potent inhibitor of several enzymes including lactate dehydrogenase (Lai 
and Blass 1984). Recently it was reported that several biological assays can be affected 
by different nanoparticles (Kroll et al 2012, Ong et al 2014). Conclusively, it is 
necessary to apply a combination of several assay systems to get robust information 
about the vitality of cells and to test the reliability of those assays in presence of ionic 
copper and CuO-NPs.  
Astrocytes exposed to CuO-NPs strongly accumulated copper in a time-, concentration-, 
temperature- and media-dependent manner (Chapter 2.1; Chapter 2.2; Chapter 2.4). In 
these performed studies was demonstrated, that an increase in the cellular copper 
contents is mirrored by a decrease in cellular vitality (Chapter 2.1-2.4). If in this case 
the cellular copper content of the exposed cells exceeded a threshold value of 10 nmol 
copper per mg protein, the vitality of the cells started to decrease (Chapter 1.3). To our 
knowledge, this is the first report of such a threshold value for the intracellular copper 
content of astrocytes regarding toxicity. Accordingly, increasing the cellular copper 
contents by facilitating the copper uptake resulted hereby in even stronger toxicity 
(Chapter 2.3).  
The presented work demonstrates, that copper can severely damage astrocytes if it is 
accumulated by those cells in high quantities (Chapter 2.1-2.4, for an overview see 
Figure 3.2). The primary source of the observed toxicity is most likely copper facilitates 
the increased generation of reactive oxygen species (Chapter 2.1; 2.3). Indeed, exposure 
of astrocytes with CuO-NPs as well as copper ions led to an increased generation of 
reactive oxygen species (Chapter 2.1; 2.3). The occurrence of reactive oxygen species 
and the loss in cell viability after exposure to CuO-NPs was drastically lowered by the 
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application of an intracellular copper ion chelator (Chapter 2.1; 2.3), indicating an 
intracellular liberation of copper ions from the internalized CuO-NPs (Chapter 1.3).  
The ability of astrocytes to store nanoparticles in vesicles was shown for iron oxide 
nanoparticles (Geppert et al. 2011, Petters et al. 2015). The endocytotic uptake of CuO-
NPs by astrocytes hints towards their vesicular storage (Figure 3.1; Chapter 1.3; 
Chapter 2.4). As endocytotic vesicles containing CuO-NPs might rapidly enter the 
lysosomal pathway, those particles will encounter an reducing and acidic environment 
(de Duve 1983, Chiang and Maric 2011, Wang et al. 2013) The stability of CuO-NPs 
under these conditions might be affected, as these conditions were already reported to 
strongly facilitate the dissolution of CuO-NPs (Studer et al. 2010, Odzak et al. 2014, 
Semisch et al. 2014, Son et al. 2015). So far it can not be excluded that the toxicity 
observed in treatments of astrocytes with CuO-NPs exclusively resulted from the 
liberation of copper ions. The lysosomal degradation of accumulated CuO-NPs and the 
liberation of copper ions were also discussed for other cell types like HeLa cells and 
A549 cells (Limbach et al. 2007, Karlsson et al. 2008, Studer et al. 2010, Semisch et al. 
2014), hinting towards a similar mechanism in astrocytes. Conclusively, astrocytes are 
most likely not able to cope with this dramatic increase in the intracellular pool of 
copper ions and the associated increase in reactive oxygen species, resulting in the 
observed decrease in the vitality of CuO-NP-treated astrocytes (Figure 3.2).  
 
Figure 3.2: Toxicity indicators in astrocytes exposed to copper. Astrocytes treated with 
ionic copper or CuO-NPs increased their intracellular copper pool (see Figure 3.1). 
Cellular copper contents exceeding threshold values of 10 nmol copper per mg protein 
result in increased generation of reactive oxygen species as well as decreased membrane 
integrity, MTT reduction capacity and cellular LDH activity. 
 
122 Summarizing discussion 
3.4 Stimulation of the astrocytic metabolism by copper 
oxide nanoparticles  
Beside the strong toxicity, as discussed above, a copper treatment of astrocytes can 
results in a variety of different consequences (Chapter 1.3). After a chronic treatment of 
astrocytes with sub-toxic concentrations of CuO-NPs the cells were able to adapt to 
increased cellular copper levels (Chapter 2.2). Astrocytes which were incubated with 
100 µM CuO-NPs for 24 h showed an accelerated glycolytic flux, increased glutathione 
and metallothioneine levels (Figure 3.3; Chapter 2.2). Interestingly, the observed effects 
were almost completely abolished in presence of an cell permeable chelator of copper 
ions (Chapter 2.2). This demonstrates the contribution of low molecular weight copper 
in the observed alterations, which might be liberated from internalized CuO-NPs as 
discussed above. Indeed, similar stimulatory effects on glycolysis, glutathione synthesis 
and metallothioneine content and were reported for astrocytes which were exposed to 
CuCl2 (Scheiber and Dringen 2011a, Scheiber and Dringen 2011b, Scheiber and 
Dringen 2013).  
 
Figure 3.3: Stimulation of the astrocytic metabolism by increased cellular copper 
levels. Increased cellular copper levels strongly affected cellular levels of 
metallothioneins (MTs) and glutathione (GSH), accelerated the glutathione export by 
the multidrug resistance protein 1 and increased the glycolytic flux.  Adapted with kind 
permission from Springer Science+Business Media: Neurochemical Research, Bulcke 
and Dringen 2015, “Handling of Copper and Copper Oxide Nanoparticles by 
Astrocytes”, Figure 3, copyright 2015. 
 
At least the stimulation of the glycolytic flux by copper seems to depend on protein 
synthesis (Scheiber and Dringen 2011b). Therefore, a potential explanation for the 
observed effects caused by a treatment of astrocytes with copper could be the activation 
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of transcription factors (Grubman and White 2014). For instance, stabilization of the 
hypoxia inducible factor (HIF) 1α was reported to stimulate the glycolytic flux in 
cultured astrocytes (Schubert et al. 2009). Further,  it was shown that at least in human 
umbilical vein endothelial cells the expression of HIF-1α regulated genes is partially 
copper dependent (Zhang et al. 2014). Nevertheless, in cultured astrocytes the 
stabilization of HIF-1α was excluded as reason for the increased glycolcytic flux in 
presence of copper (Scheiber and Dringen 2011b).  
An alternative transcriptional activator, the nuclear factor erythroid 2-related factor 2 
(Nrf2), was stimulated in A172 glioblastoma cells upon exposure to copper and other 
heavy metals (Simmons et al. 2011). Nrf2 has a central role in the activation of the 
transcription of metal response elements and antioxidant response elements (Figure 3.4, 
Song et al. 2014).  
 
 
Figure 3.4: Scheme of the activation of nuclear factor erythroid 2-related factor 2 
(Nrf2). The transcription factor Nrf2 is activated by metals or oxidative stress. 
Activated Nrf2 is translocated to the nucleus and binds to antioxdative response 
elements (ARE) or metal response elements (MRE) and activates the transcription of 
the indicated selected targets (Tufekci et al. 2011, Song et al. 2014). 
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The stimulation of those gene elements results in increased expression of glycolytic 
enzymes, enzymes involved in the glutathione homeostasis and metallothioneines 
(Tufekci et al. 2011, Song et al. 2014). Therefore, the activation of Nrf2 in astrocytes 
upon exposure to CuCl2 or CuO-NPs could explain the stimulated expression of 
proteins which mediate for the stimulated glycolysis, increased glutathione synthesis 
and metallothioneine levels (Figure 3.4).  
The effective stimulation of various protective pathways under copper mediated stress 
underlines the role of astrocytes in the brain as metal sink, central element of 
detoxification and metabolic support of neurons (Tiffany-Castiglioni and Qian 2001, 
Hirrlinger and Dringen 2010, Brekke et al. 2015). 
 
3.5 Reflections on the in vivo relevance of the data 
obtained 
The results of this thesis clearly show that CuO-NPs in high concentrations have 
adverse effects on cultured primary astrocytes. This data in combination with the results 
of others shows that CuO-NPs are strongly toxic and exert severe deleterious effects on 
different cell types (Karlsson et al. 2009, Ahamed et al. 2015, Ivask et al. 2015). 
However, to perform a complete risk assessment for CuO-NPs, additional information 
has to be obtained (Figure 3.5).  
CuO-NPs can be fabricated or unintentionally released into the environment (Figure 
3.5). Several studies reported the strong ecotoxicity of CuO-NPs, as lately reviewed 
(Bondarenko et al. 2013). However, also humans could be exposed to CuO-NPs. The 
most endangered persons are those constantly exposed to CuO-NP containing exhausts, 
smoke and fumes (Szymczak et al. 2007, Balkhyour and Goknil 2010). In an 
occupational exposure scenario especially welders are most probable exposed to CuO-
NPs (Balkhyour and Goknil 2010, DFG 2012, Lehnert et al. 2012, DFG 2015). Workers 
in this branch of industry are strongly exposed to nanoparticles and are known to suffer 
from severe health impairments such as pulmonary inflammation, chronic kidney and 
liver damage (Balkhyour and Goknil 2010, DFG 2012, Lehnert et al. 2012, Andujar et 
al. 2014). The threshold limit value for copper fumes in a daily exposure scenario 
without adverse health effects is at 0.1 mg per m³ ambient air at the workplace (DFG 
2012, 2015).  
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Figure 3.5: Schematic overview of the risk assessment of nanoparticles. Databases with 
increasing amounts of studies will help in the risk assessment of nanoparticles for the 
environment and human health.  
 
Several studies report that nanoparticles are able to enter the body by different routes, 
but inhalation is the most probable uptake route for nanoparticles (Kreyling et al. 2002, 
Hoet et al. 2004, Oberdörster et al. 2004, Oberdörster et al. 2005). Nanoparticles are 
able to enter the brain upon inhalation either directly by translocation over the nerve 
endings of the olfactory bulb or indirectly after uptake into the blood stream (Kreyling 
et al. 2002, Oberdörster et al. 2004, Sharma and Sharma 2012). However, the amount of 
nanoparticles which might reach the brain through the bloodstream and subsequently 
enter the brain by transcytosis through the endothelia cells of the brain capillaries might 
be very low for various types of nanoparticles (Kreyling et al. 2002). This view may be 
not correct for CuO-NPs, as CuO-NPs which were applied into the bloodstream of rats 
are reported to disrupt the integrity of the blood brain barrier and thereby facilitate this 
entering into the brain (Sharma and Sharma 2012).  
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In the presented work CuO-NPs were applied in toxic and sub-toxic concentrations over 
a period of maximal 24 h, which demonstrates already the limitation of the performed in 
vitro experiments. However, the obtained results on cultured astrocytes, which 
demonstrated the strong uptake and toxicity of CuO-NPs and ionic copper (Chapter 2.1-
2.4) might help to explain the deleterious effects of CuO-NPs, which were observed in 
the subsequent in vivo experiments (Migliore et al. 2015). In vivo injection and 
inhalation experiments with CuO-NPs on rats showed that the treated animals suffered 
severe cognitive impairments and damage of the blood brain barrier (Sharma and 
Sharma 2007, An et al. 2012, Sharma and Sharma 2012). However, the role of 
astrocytes in this process of neurodegeneration was so far not elucidated. Taking into 
account that astrocytes play a key role in the brain homeostasis and that those cells are 
able to accumulate CuO-NPs over time and strongly react to this treatment, it is 
necessary to perform further in vivo inhalation or injection studies with a focus on 
astrocytes in the brain, to evaluate the potential role of these cells in the neurotoxicity of 
CuO-NPs. 
3.6 Future perspectives 
CuO-NPs synthesized for this work were a good tool to investigate the accumulation 
and toxicity of CuO-NPs in cultured astrocytes. However, the hydrodynamic size of the 
particles used in dispersion is relatively large and the stability of the particles is poor in 
comparison to other types of nanoparticles (Geppert et al. 2011, Luther et al. 2011, 
Petters et al. 2014). Several improvements of the particle synthesis are possible to 
obtain smaller and more stable particles. The current method describes the alkaline 
precipitation of CuO-NPs with a subsequent coating (Chapter 2.1). An improvement of 
this method is the alteration of the synthesis method by alkaline precipitation of CuO-
NPs in presence of the coating material (Lüken 2014). This improved synthesis method 
harvested particles with a hydrodynamic diameter of 59 nm in water, which is half of 
the hydrodynamic diameter of the CuO-NPs used in the presented work. To improve the 
stability of DMSA-coated CuO-NPs against agglomeration in media containing low 
amounts of protein, an additional coating of CuO-NPs with proteins, as described in 
chapter 2.4 for BSA, could be used for future studies. As so far no data on the long term 
stability of protein coated CuO-NPs were obtained, such experiments need to be 
conducted. The particle dissolution of CuO-NPs should be reduced by modification of 
the nanoparticle surface, for example with carbon or natural organic matter (Odzak et al. 
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2014, Son et al. 2015). In any case, altering the synthesis method of CuO-NPs involves 
a detailed characterization of the particles to ensure stability and reproducibility. As 
described previously, small changes in the particle properties could lead to differences 
in the bioavailability and toxicity (Chapter 3.1). 
Fluorescent nanoparticles were reported to be a good tool for the intracellular 
visualization and for tracking the fate of the nanoparticles in cells (Kim et al. 2008, 
Wang et al. 2015). DMSA as coating material allows the introduction of fluorescent 
dyes as it was already done for iron oxide nanoparticles (Luther et al. 2013, Petters et al. 
2014). In these reports, the thiol groups of the DMSA were functionalized with a 
fluorescent molecule. All thiol reactive dyes could possibly be introduced to DMSA. 
Fluorescent CuO-NPs should be synthesized and characterized to analyze the fate of 
those nanoparticles in cells.  
The intracellular localization of nanoparticles can be analyzed by electron microscopy 
(Geppert et al. 2011). However, the limitation of this technique is that it just gives 
insight if nanoparticles are present or stored in vesicular structures. Several fluorescent 
markers and antibodies for the visualization of vesicles, different stages of endosomes 
and lysosomes are commercially available. These markers in combination with the 
fluorescently labeled CuO-NPs could visualize the uptake pathway and fate of those 
nanoparticles in cells. Moreover, those studies should be performed in cultured 
astrocytes, to verify the hypothesis that CuO-NPs are present in lysosomes after the 
accumulation, as already confirmed for fluorescent labeled iron oxide nanoparticles 
(Petters et al. 2015).   
In the presented work, endocytosis inhibitors were used to investigate the uptake 
mechanism of CuO-NPs by astrocytes. However, the low specificity of the used 
inhibitors is the limitation of this method (Vercauteren et al. 2010). For a detailed 
analysis of the uptake mechanism, the small interfering RNA (siRNA) technique could 
be used to specifically suppress targeted endocytotic pathways (Chang et al. 2014). 
Nevertheless, it should be taken into account that endocytosis is a very dynamic process 
in which alternative pathways for the uptake of material could be used if one pathway is 
shut down (Huth et al. 2006, Vercauteren et al. 2010). Despite this disadvantage, the 
siRNA technique should be applied to identify the endocytotic pathways involved in the 
uptake of CuO-NPs. 
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CuO-NPs severely reduced the vitality of astrocytes if they were accumulated in high 
amounts. This toxicity was attributed to the extended generation of reactive oxygen 
species (Chapter 2.1). In vivo experiments with mice and in vitro experiments with 
podocytes showed, that a treatment with CuO-NPs results in oxidative DNA damage 
and the formation of micronuclei (Perreault et al. 2012, Song et al. 2012). The 
verification of oxidative DNA damage and the formation of micronuclei was so far not 
elucidated for astrocytes and therefore should be performed. Additionally, the pathway 
of cell death in astrocytes exposed to CuO-NPs was so far not revealed. Several cellular 
signaling pathways can be affected by the presence of copper (Grubman and White 
2014). Recently it was shown, that the CuO-NPs induced toxicity is regulated at least in 
fibroblasts and keartinocytes by the mitogen-activated protein (MAP) kinase and p53 
(Luo et al. 2014). Further it was reported, that at least in A549 lung epithelia cells CuO-
NPs induced autophagy, as shown by reduced levels of caspase-3 and microtubule-
associated protein 1 light chain 3 (LC3) (Sun et al. 2012). Westen blot experiments with 
CuO-NP treated astrocytes should be performed to elucidate the participation of the 
MAP kinase, p53, caspase-3 and LC3 in the cell death. 
Astrocytes treated with sub-toxic concentrations of CuO-NPs showed a stimulated 
glycolytic flux and increased their glutathione and metallothioneine levels (Chapter 
2.2). However, the mechanism behind these protective measures is so far not known and 
should be elucidated. As discussed above, a potential target involved in the upregulation 
of these processes could be the transcription factor Nrf2 (Chapter 3.4). Recently it was 
shown that tetramethylpyratine (TMP), an enhancer of Nrf2 activity, could protect PC-
12 cells from CoCl2 derived toxicity (Guan et al. 2015). TMP enhanced the activity of 
Nrf2 and γ-glutamylcysteine ligase, whereas the hypoxia-inducible factor 1α and the 
NADPH oxidase 2 mediated generation of reactive oxygen species was suppressed 
(Guan et al. 2015). The involvement of Nrf 2 was determined in this study by Western 
blot analysis and the transcriptional activity was determined by a luciferase reporter 
gene assay (Guan et al. 2015). Similar studies should be performed to investigate 
wheather TMP can protect astrocytes from CuO-NP derived toxicity and wheather Nrf2 
is involved in the upregulation of the observed protective mechanism. 
The tissue copper content strongly differs between certain brain regions (Davies et al. 
2013). For example, with 11.4 µg copper per g wet weight the substantia nigra contains 
almost double the amount of copper compared to the cerebellum or the visual cortex 
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(Davies et al. 2013). Certain cell types like astrocytes are more efficient to accumulate 
copper that other cell types, for example neuronal cells (Scheiber et al. 2010, Liu et al. 
2013). Different cell types can also have different capabilities to take up nanoparticles, 
as recently shown for the uptake of iron oxide nanoparticles in different brain cells 
(Petters et al. 2015). Therefore it is of high interest to study the uptake and also the 
toxicity of CuO-NPs in different cell types to investigate whether certain types of cells 
are more susceptible to the CuO-NP derived toxicity. Those in vitro experiments can be 
used to clarify the mechanisms behind the toxicity. It will be necessary to conduct in 
vivo experiments to transform the results obtained from such in vitro experiments to the 
occupational exposure scenario. In vivo inhalation studies should be performed to 
clarify if harmful amounts of CuO-NPs can even reach the brain trough inhalation and 
how the distribution of those particles will take place between different organs and cell 
types. As recently reviewed, only few in vivo inhalation studies were conducted with 
CuO-NPs which mostly focused on the lung toxicity of this material (Ahamed et al. 
2015). Only one in vivo study focused on the neurotransmitter changes of the brain after 
intranasal instillation of CuO-NPs (Zhang et al. 2012). Additionally, some in vivo 
injection studies with CuO-NPs were performed that showed the disruption of the blood 
brain barrier, neuronal damage and behavioral changes of the test animals (An et al. 
2012, Sharma and Sharma 2012).  
Several adverse effects of CuO-NPs were discussed up to this point, but so far not much 
was told about the potential benefits of CuO-NPs. Among their broad range of 
applications (Chapter 1.1), CuO-NPs could potentially be used as biomedical agent. As 
mentioned in the previous chapters it was reported, that CuO-NPs can be accumulated 
by several cell types including astrocytes. Additionally it was shown, that CuO-NPs are 
prone to dissolve over time. If the properties of CuO-NPs could be altered in such a way 
that the release of low molecular weight copper ions is defined in a slow manner, those 
particles could be used to serve as copper depot. Astrocytes, which are suggested as a 
fulcrum of the copper homeostasis in brain (Scheiber and Dringen 2013), can be seen as 
a copper storing and distributing cell type (Tiffany-Castiglioni et al. 2011). Several 
neurodegenerative disorders are linked to disturbances in the copper metabolism of the 
brain (Grubman et al. 2014a, Scheiber et al. 2014). Menkes disease is characterized by 
decreased copper levels in the body due to a mutation of the copper transport protein 
ATP7A, which results in a decreased copper absorption from the intestine (Barnes et al. 
2005, Ahuja et al. 2015). In contrast to Menkes disease in which a general copper 
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deficiency is a hallmark, Alzheimer’s disease and Parkinson’s disease are characterized 
by a local copper deficiency in which either the proteins amyloide-β or α-synuclein 
aggregate and strongly bind copper (Ahuja et al. 2015, Dusek et al. 2015). 
Subsequently, the copper bound to those aggregates is unavailable for neurons (Ahuja et 
al. 2015, Dusek et al. 2015). Amyotrophic lateral sclerosis is another neurodegenerative 
disorder in which a defective superoxide dismutase 1 has a decreased metal binding 
capacity connected with a toxic gain of function (Roberts et al. 2014). Copper 
delivering therapies are currently under investigation for the treatment of the mentioned 
neurodegenerative disorders (Iakovidis et al. 2011, Bica et al. 2014, Grubman et al. 
2014b, Roberts et al. 2014). CuO-NPs should be utilized in these deficiency scenarios to 
supply neurons and other cells of the brain with the essential copper. Several animal 
model systems for different neurodegenerative disorders are commercially available 
(Ghorayeb et al. 2011, Bezard et al. 2013, Ribeiro et al. 2013), in which CuO-NPs 
should be tested for their treatment capability of copper deficiency. 
In contrast to the copper depot approach, CuO-NPs could also be utilized as anti-cancer 
tool. In this scenario, CuO-NPs would be selectively directed to cancer cells and cause 
death of these cells. It was already shown that cancer cells seem to be more sensitive to 
CuO-NPs in comparison to normal cells (Wang et al. 2012). The CuO-NPs of the here 
present work were tested in astrocytes, therefore a direct comparison to glioma cell lines 
like C6-cells should be conducted to investigate weather CuO-NPs affect cancer cells 
stronger than normal cells. In case this hypothesis can be verified, approaches to target 
and direct those nanoparticles specifically to selected cancer cells by surface 
modifications, for examples with glycans, peptides or antibodies, should be performed. 
In case the targeting of the CuO-NPs to cancer cells is effective in cancer cell 
containing mixed cell cultures, these CuO-NPs should be tested in vivo for their ability 
to selectively reach and kill cancer cells. The focus of research on nanoparticles for 
cancer therapy and diagnostic over the last years was predominantly performed for iron 
oxide, gold, silica and polymeric nanoparticles (Ediriwickrema and Saltzman 2015, 
Sharma et al. 2015). Those nanoparticles were mainly used as carriers for drugs or 
siRNA delivery, with the advantage of a low toxicity of the nanoparticle core material 
(Ediriwickrema and Saltzman 2015, Sharma et al. 2015). Several nanoparticles based 
drugs for cancer therapy are currently in clinical trials, whereas only few are approved 
for usage (Wicki et al. 2015). However, CuO-NPs might be a promising alternative to 
the currently investigated nanoparticles in cancer therapy. 
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